Skip to main content
. 2021 May 4;137(6):1043–1053. doi: 10.1097/AOG.0000000000004384

Fig. 3. Application of the imiquimod immunomodulator to the cervix. Beginning of the application (A); imiquimod reaching the entire transformation zone (B); imiquimod covering all lesion and transformation zone (C).

Fig. 3.

Fonseca. Topical Imiquimod for HSIL of the Cervix. Obstet Gynecol 2021.